Likewise, genetic alterations in biliary tract cancers can be directed toward targets involving IDH1, FGFR2, and v-raf murine sarcoma viral oncogene homolog B1 (BRAF) [37]. The gene discussed is BRAF; the disease is biliary tract cancer.